Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 2, no: 8 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
Related structures:
AlphaFold database: E9B2Z4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
DOC_CKS1_1 | 15 | 20 | PF01111 | 0.335 |
DOC_PP1_RVXF_1 | 84 | 90 | PF00149 | 0.653 |
DOC_PP2B_LxvP_1 | 62 | 65 | PF13499 | 0.481 |
DOC_PP4_FxxP_1 | 81 | 84 | PF00568 | 0.209 |
DOC_WW_Pin1_4 | 14 | 19 | PF00397 | 0.335 |
LIG_Actin_WH2_2 | 25 | 40 | PF00022 | 0.490 |
LIG_BRCT_BRCA1_1 | 25 | 29 | PF00533 | 0.355 |
LIG_BRCT_BRCA1_1 | 75 | 79 | PF00533 | 0.408 |
LIG_BRCT_BRCA1_1 | 90 | 94 | PF00533 | 0.630 |
LIG_CAP-Gly_1 | 126 | 133 | PF01302 | 0.725 |
LIG_eIF4E_1 | 43 | 49 | PF01652 | 0.447 |
LIG_FHA_1 | 45 | 51 | PF00498 | 0.430 |
LIG_FHA_1 | 88 | 94 | PF00498 | 0.555 |
LIG_IRF3_LxIS_1 | 33 | 40 | PF10401 | 0.683 |
LIG_LIR_Apic_2 | 6 | 12 | PF02991 | 0.469 |
LIG_LIR_Apic_2 | 80 | 84 | PF02991 | 0.215 |
LIG_LIR_Gen_1 | 107 | 114 | PF02991 | 0.605 |
LIG_LIR_Gen_1 | 26 | 37 | PF02991 | 0.459 |
LIG_LIR_Gen_1 | 40 | 51 | PF02991 | 0.458 |
LIG_LIR_Nem_3 | 26 | 32 | PF02991 | 0.351 |
LIG_LIR_Nem_3 | 40 | 46 | PF02991 | 0.463 |
LIG_LIR_Nem_3 | 8 | 13 | PF02991 | 0.461 |
LIG_NRBOX | 47 | 53 | PF00104 | 0.447 |
LIG_PDZ_Class_3 | 128 | 133 | PF00595 | 0.730 |
LIG_Pex14_1 | 9 | 13 | PF04695 | 0.461 |
LIG_SH2_CRK | 43 | 47 | PF00017 | 0.447 |
LIG_SH2_GRB2like | 43 | 46 | PF00017 | 0.484 |
LIG_SH2_NCK_1 | 43 | 47 | PF00017 | 0.447 |
LIG_SH2_STAT5 | 106 | 109 | PF00017 | 0.586 |
LIG_SH2_STAT5 | 120 | 123 | PF00017 | 0.571 |
LIG_SH2_STAT5 | 43 | 46 | PF00017 | 0.451 |
LIG_SUMO_SIM_anti_2 | 44 | 50 | PF11976 | 0.480 |
LIG_WRC_WIRS_1 | 78 | 83 | PF05994 | 0.308 |
MOD_GSK3_1 | 37 | 44 | PF00069 | 0.487 |
MOD_GSK3_1 | 52 | 59 | PF00069 | 0.355 |
MOD_GSK3_1 | 73 | 80 | PF00069 | 0.406 |
MOD_N-GLC_1 | 2 | 7 | PF02516 | 0.626 |
MOD_N-GLC_1 | 44 | 49 | PF02516 | 0.480 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.648 |
MOD_NEK2_1 | 105 | 110 | PF00069 | 0.509 |
MOD_NEK2_1 | 28 | 33 | PF00069 | 0.445 |
MOD_NEK2_1 | 37 | 42 | PF00069 | 0.456 |
MOD_NEK2_1 | 52 | 57 | PF00069 | 0.294 |
MOD_NEK2_1 | 73 | 78 | PF00069 | 0.283 |
MOD_NEK2_2 | 58 | 63 | PF00069 | 0.288 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.553 |
MOD_PKA_2 | 37 | 43 | PF00069 | 0.463 |
MOD_Plk_1 | 44 | 50 | PF00069 | 0.480 |
MOD_Plk_4 | 44 | 50 | PF00069 | 0.453 |
MOD_Plk_4 | 73 | 79 | PF00069 | 0.430 |
MOD_ProDKin_1 | 14 | 20 | PF00069 | 0.355 |
TRG_DiLeu_BaLyEn_6 | 62 | 67 | PF01217 | 0.589 |
TRG_ENDOCYTIC_2 | 109 | 112 | PF00928 | 0.424 |
TRG_ENDOCYTIC_2 | 43 | 46 | PF00928 | 0.355 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCE7 | Leptomonas seymouri | 56% | 100% |
A0A0S4IHK1 | Bodo saltans | 30% | 100% |
A0A1X0NU87 | Trypanosomatidae | 55% | 100% |
A0A3S7X5Q0 | Leishmania donovani | 93% | 100% |
A0A422MY14 | Trypanosoma rangeli | 39% | 100% |
A4HKK4 | Leishmania braziliensis | 84% | 100% |
A4I836 | Leishmania infantum | 93% | 100% |
D0AAA3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 49% | 100% |
Q4Q562 | Leishmania major | 93% | 100% |